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Summary: The antiepileptic drugs phenobarbital and phenytoin were determined in serum by enzyme immuno-
assay (Emit, Syva Corp.) and gas-liquid chromatography. The Emit assays were mechanized by the use of an Eppen-
dorf analyzer 5010. The precision of the Emit system was sufficient (coefficient of variation within series 6-13%
and from day to day 8—15% with various calibrators and control sera). Moreover the Emit method is rapid, specific
and easy to perform. The procedure requires only 10 of serum per determination. A disadvantage however is the
high cost of the reagents. A comparison of the results obtained by Emit and gas-liquid chromatography in a series of
about 50 patients showed a good correlation between both methods (correlation coefficient r = 0.968 for pheno-
barbital and 0.978 for phenytoin).
Bestimmung von Phenobarbital und Phenytoin im Serum mit einem mechanisierten Enzymimmuntest (Emit) im Ver-
gleich zu einer gas-liquid chromatographischen Methode
Zusammenfassung: Die antiepileptischen Pharmaka Phenobarbital und Phenytoin wurden mit einem Enzymimmuntest
(Emit, Syva Corp.) und einer gas-liquid chromatographischen Methode bestimmt. Die Emit Tests wurden durch Ver-
wendung eines Eppendorf Enzymautomaten 5010 mechanisiert. Die Präzision des Emit Systems war ausreichend (Varia-
tionskoeffizient in der Serie 6—13% und von Tag zu Tag 8—15% mit verschiedenen Kalibratoren und Kontrollseren).
Darüber hinaus ist das Emitverfahren schnell, spezifisch und leicht durchführbar. Für eine Bestimmung werden nur
10 Serum benötigt. Nachteilig sind jedoch die hohen Kosten der Reagenzien. Ein Vergleich der Ergebnisse, welche
mit Emit und Gas-Liquid-Chromatographie in einer Serie von etwa 50 Patienten erhalten wurden, zeigte eine gute Über-
einstimmung beider Methoden (Korrelationskoeffizient r = 0,968 für Phenobarbital und 0,978 für Phenytoin).
Introduction these compounds have been described. These techniques
. ~. . . r r , x r .. however, are rather time consuming. Recently homo-The efficiency and safety of the treatment of epileptic us e ̂ ^^ for the quantitative
patients with anti-epdeptic drugs has been consider- measurement of phenobarbital and phenytoin have
ably Ceased by monitoring the serum level of these become commercia]ly available which are based on the
drugs. The quantitative determination of serum anti- me Multi lied Irmnunoassay Technique» (Emit)
epdeptic drug levels facilitates individualization of dosage fhe ̂  m has feeen demonstrated to be a
regimens reveals irregular drug intake and identifies the ^^ ̂  fof drugs Qf afeuse ̂  urine (4> 5) ,n CQntrast
responsible agent in mtoxicated patients on multiple tQ Qther inmmn techniques homogeneous enzyme
drug therapy (1, 2). Phenytoin2) and phenobarbital*) ^unoassays can easily be mechanized. The adaptation
belong to the most commonly used drugs in the treat- Qf ̂  ̂  tem tQ ̂  centrifuga] ̂  has
inent of epuepsy. In the Pa$t few years many gas-liquid been rted
Chromatographie methods for the determination ot
In the present study a rapid mechanized procedure for
the quantitation of phenytoin and phenobarbital by
*) Parts of this study have been reported at the 2nd European Emit was evaluated using an Eppendorf analyzer 5010.
>) S^p^S^SSn^116 ·976' » ™»s ̂ tained by this method are compared
3) S-Ethyl-S-phenytbarbituric acid. with those determined by gas-liquid chromatography.
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Material and Methods
Origin of specimens
Serum samples (n = 90) containing phenytoin and phenobarbital,
a metabolite of primidone, were obtained from epileptic patients
of our hospital. Control sera were purchased from Syva Corpo-
ration (AED, antiepileptic drug control) and from Laboratories
Biotrol in Paris (Biotrol-therapeutique).
Materials
The reagents for the enzyme immunoassay (Emit) were purchased
from Syva Corp. (Palo Alto, California 94309). Substances tested
for cross-reactivity were a generous gift of the manufacturers of
the drugs mentioned by trade names.
Gas-Liquid Chromatography
The determination of phenobarbital and phenytoin by gas-
liquid chromatography was carried out according to a modified
version of the procedure viFiereck & Tietz (8) without methyla-
tion (K lpmann, W. R. in preparation).
2 ml of saturated (NH4)2SO4 solution is added to 1 ml of the
serum sample. The mixture is extracted 3 times with 5 ml
chloroform. The organic phase is dried over Na2SO4 and evapor-
ated. The residue is washed down from the tube sides with 200
μΐ ethyl acetate/acetic acid (volumes, 100 ml + 1 ml) and eva-
porated again. Then the dried residue is dissolved in 100 μΐ of
ethyl acetate/acetic acid (volumes, 100 ml + 1 ml); 2 μΐ of this
solution are injected into the gas Chromatograph. A Varian model
1800 gas Chromatograph (Varian, Darmstadt, FRG) equipped
with a dual hydrogen flame detector is used. Glass columns are
silanised (180 cm X 2.2 mm, i. d.). They are packed with 3%
SP 2250 DA on 100-120 mesh Chromosorb WHP (Supelco,
Bellefonte, Pennsylvania). Carrier gas flow rate is 40 ml/min,
hydrogen 30 ml/min, and air 300 ml/min. The column tempera-
ture is maintained at 230 °C, the inlet and the detector at 260 °C.
The concentration of drugs is calculated by means of the slope of
the regression line from the peak heights of the injected standard
concentrations.
Enzyme immunoassay (Emit)
The original procedure of the Emit antiepileptic drug assays was
adapted to the Eppendorf analyzer 5010 (Eppendorf, Hamburg,
FRG).
Serum and reagent A, which contains the antibodies, the
enzyme substrate glucose-6-phosphate and NAD* are pre-
incubated for 15 minutes at 25 °C. Then the reaction is started
with reagent B containing glucose-6-phosphate dehydrogenase
coupled to phenytoin or phenobarbital (tab. 1).
Tab. 1. Test procedure for the Emit phenobarbital and phenytoin
assay with the Eppendorf analyzer 5010.
Serum 10 Mi
Reagent. A (antibody/substrate/NAD+)a 500 μΐ
Preincubation: 15 minutes at 25 °C
Reagent Β (drug-enzyme conjugate)3 100 μΐ
Wavelength: 334 nm, program for aspartate amino-transferase,
temperature 25 °C. Fkst reading of absorbance 30 seconds and
last reading 180 seconds after addition of reagent B.
a) Reagent A is diluted 1:13.5 and reagent Β 1:2.5 with 55 mmol/1
Tris-HCl buffer (pH 7.9).
The first reading of absorbance is performed 30 seconds and the
last reading 180 seconds after the addition of reagent Β at a wave-
length of 334 nm. The program for aspartate aminotransferase
of the Eppendorf analyzer is suited for this procedure. The ab-
sorbance differences (ΔΑ) obtained are used to calculate the
results. From each absorbance reading Δ A the absorbance of
the zero standard ΔΑ0 is subtracted. As these absorbance
differences are greater than those obtained by the original
method, they have to be divided by a constant factor before
being plotted on the Emit graph paper (a modified logit function
paper).
Calibrators and all samples were determined in duplicate.
Precision and accuracy were checked within every run. Control




Emit standard curves obtained by the Eppendorf analyzer
5010 are shown in figures 1 and 2. These calibration
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Fig. 2. Typical Emit standard curve for phenytoin with the
• Eppendorf analyzer 5010.
performance specifications for tlie original method. The
range of linearity encompasses values from 2.5—30 mg/l
(9.9-118.9 μιηοΐ/ΐ) with the phenytoin assay and from
5-̂ 80 mg/l (21.5-344.5 μπιοΐ/ΐ) with the phenobarbital
assay. Concentrations below 2.5 mg/l phenytoin and 5.0
mg/l phenobarbital are regarded as being below the detec-
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tion limit. Samples with concentrations of phenytoin
above 30 mg/1 and phenobarbital above 80 mg/1 have
to be diluted with a 70 g/1 bovine albumin solution.
The change of absorbance during the 150 seconds reading
time is shown for various pheriobarbital concentrations
in figure 3. Similar results were obtained by the Emit
phenytoin assay. There is a non-linearity between
30 and 80 seconds, then the curve becomes almost
linear. The 150 seconds reading time ensures an adequate
absorption change, for sufficient sensitivity. The absorb-
ance change produced by the blank is considerable. The
difference between this blank value and the absorbance
changes caused by the various calibrators is compara-
tively low. This ratio appears to be unfavorable with
respect to the precision. The same disadvantages were








Fig. 3. The absorbance change of the Emit assay for various
phenobarbital concentrations. Blank *—A, 5,0 mg/1
•—· and 80 mg/1 ·—· phenobarbital.
Precision
The precision of the Emit system for the quantitative
determination of phenobarbital and phenytoin in
serum at various concentrations of calibrators and
commercial control sera is shown in table 2, With most
of the calibrators and control sera tested the coefficient
of variation withiri series ranged from 6—13% and from
day to day from 8—15%. The precision within series
of gas-liquid chrpmatography was determined by the
repeated analysis (n = 10) of a spiked human serum
containing phenobarbital (2 .Q mg/1) and phenytoin
(20 mg/1). The average phenobarbital concentration
found was 20.0 mg/1 with a coefficient of variation
of 3,8%. The average phenytoin' concentration was
19.2 mg/1 with a coefficient of variation of 4.7 %.
From day to day variation was determined by analyzing
Tab. 2. The precision of the Emit system for the quantitative
determination of phenobarbital and phenytoin in
serum at various concentrations of calibrators and com-
mercial control sera. Assays were performed in dupli-
cates on 20 days (n = 40).
Pheno- Precision of the pheno-
barbital barbital assay
or pheny- From day Within
toin con- to day series
centra- χ (CV)a χ (CV)
tion
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a) mean value with coefficient of variation in parenthesis; b) Bio-
trol-therapeutique (Laboratoires Biotrol); c) AED control (Syva).
the same spiked serum at 13 days. The average pheno-
barbital concentration was 20.0 mg/1 with a coefficient
of variation of 5.1 % and the mean phenytoin concen-
tration 19.8 mg/1 with a coefficient of variation of
4.3%. At a phenobarbital or phenytoin concentration
of 20.0 mg/1 the precision of the Emit system was lower
than that of gas-liquid chromatography.
Accuracy
The results for the recovery of phenobarbital and
phenytoin by the Emit system are shown in table 3.
Both compounds were added to pooled drug-free human
serum. The recovery at various concentrations between
10 and 50 mg/1 was adequate: 93-99% for phenobarbital
and 93—101 % for phenytoin.
Tab. 3. The recovery of phenobarbital and phenytoin by the
Emit system in spiked serum samples. Determinations
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In order to study the linearity of the Emit system, sera
from patients with high concentrations of phenobarbital
and phenytoin were diluted with a 70 g/1 albumin solu-
tion. The results shown in table 4 indicate a satisfactory
linearity in the range tested.
Tab. 4. The linearity of the Emit phenobarbital and phenytoin
assay. Samples from patients containing the indicated






















































Furthermore phenobarbital and phenytoin levels were
determined by gas-liquid chromatography and Emit in
sera from patients on a medication of primidone ( = 57)
and phenytoin (n = 43).
For the measurement of phenobarbital, the least-
squares regression analysis of 57 specimens (fig. 4)
showed the slope of the line to be 0.95. The value of
the intercept was 1.39 mg/1. Random error was esti-
mated at 11.5 mg/1 from the standard error (10). The
correlation between the results was high (r = 0.968).
For a gas-liquid Chromatographie value of 30 mg/1, the
Emit procedure would give an average value of 29.9
mg/1 (standard error Sy = 11.5 mg/1).
For the determination of phenytoin the values of slope
and intercept were, respectively, 0.93 and 1.16 mg/1
(fig. 5). The results obtained with both methods corre.-
lated well (coefficient of correlation r = 0.978). For a
gas-liquid dhrornatographic value of 15.0 mg/1 the Emit
phenytoin assay would give an average value of 15.1
mg/1 (standard error Sy = 7.3 mg/1).
50 mo 15.0 20.0 25.0 30:0
Phenytoin (Gos-liquio chromatography) [mg/l]
Fig. 5. Serum phenytoin concentrations as measured by Emit
and gas^liquid chrpmatography (n = 43). Slope: 0.93,
intercept: 1.16 mg/1, correlation coefficient: 0,978.
Both Emit assays appeared to correlate sufficiently
with gas-liquid chromatography. The use of the Emit
results would not change the clinical interpretation.
Similar results have been reported for the Emit techni-
que performed on Gilford or Beckman instruments
(9,11-13) and on the Rotochem II (7).
0.0
OJD 10.0 20.0 30.0 40:0 50.0 60.0 70D
Phenoborbitol (Gos-liquid chromotogrophy)[mg/l]
Fig. 4. Serum phenobarbital concentrations äs measured by
Emit and gas-liquid chromatography (n = 57). Slope:
0.95, intercept: 1.39 mg/1 correlation coefficient:
0.968.
Specificity
The specificity of the Emit assays was tested by the
determination of the cross-reactivity with structurally
related compounds and other antiepileptic drugs. The
results obtained with spiked human serum samples are
shown in table 5. For each drug the concentration was
determined at which it exerts an absorbance equivalent
to 5 rng/1 phenobarbital or phenytoin in the corre-
sponding Emit assay. The Emit phenytoin assay seemed
to be very specific. In addition to the phenytoin meta-
bolite, SHtp-hydroxypheny^S-phenylhydantoin, only
mephenytoin slightly cross reacted in this assay. It
should be noted that phenytoin-3-norvälme is apparently
completely metabolized in vivo so that serum levels
cannot be determined. With serum samples from patients
(n = 20) receiving various drugs other than phenytoin no
positive results were observed.
The Emit phenpbarbital assay was less specific. Methyl-
phenobarbital, cyclobarbital, cyclppal, and amobarbital
showed a cross-reaction. Serum ßamples from patients
J. Clin. Chem. Clin. Biochem. / Vol. 15,1977 / No. 6
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Tab. 5. Cross-reactivity of drugs in serum8 with the Emit pheno-
barbital and phenytoin assay.
Emit phenobarbital assay










Heptabarbital (Medo min) NR




Phenytoin (Zentropil) ι NR
5-(p-Hydroxyphenyl)-5-phenylhydantoin NR



































a) drugs were added to normal human serum; b) concentrations
exerting an absorbance equivalent to 5.0 mg/1 phenobarbital or
phenytoin; c) no reaction up to concentrations of 1000 mg/1.
receiving drugs such as primidone and methylpheno-
barbital, which are converted to phenobarbital, yielded
positive results. Phenobarbital levels are very often used
for monitoring primidone therapy as they fluctuate less
than primidone levels. With serum samples from patients
(n = 20) not taking ariy of the drugs mentioned above
but receiving phenytoin and/or other drugs no false
positive results were obtained.
Interferences
Bilirubin concentrations up to 300 jumol/l did not affect
the results of both assays. Extremely lipemic and hemo-
lytic sera could not be analyzed by this method. Hemo-
globin concentrations up to 2.0 g/1 showed no inter-
ference. With the determination of phenobarbital by
gas-liquid chromatography a slight interference of
phenylethylmalondiamide, a metabolite of primidone,
was observed, owing to an incomplete separation of
the two substances.
Clinical experience
The measurement of phenytoin and phenobarbital
appears to be of great clinical value. In many cases
irregular drug intake and inadequate dosage could be
objectified and the diagnosis of an intoxication con-
firmed. To illustrate the clinical relevance of the deter-
mination of antiepileptic drug levels an example from
our pediatric clinic is given in figure 6. A twelve year
old girl treated with phenytoin and primidone, was
sent to our pediatric clinic because of toxic symptoms
such as nystagmus and ataxia, which increased during
the following days. The clinical signs pointed to an
intoxication by phenytoin.
This diagnosis was confirmed by the determination of
the serum levels of phenobarbital and phenytoin. The
serum levels of phenytoin were far above the thera-
peutic range, whereas the phenobarbital concentrations
only slightly exceeded the recommended values. After
the phenytoin medication was discontinued the pheny-








Fig. 6. Comparison of clinical signs and serum drug levels
in a patient intoxicated by phenytoin.
Phenobarbital level: β—·, phenytoin level: ·—·
Borderline of toxic level with phenobarbital (40 mg/1)
and with phenytoin (20 mg/1) ++.
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Conclusion
According to our experience the Emit assays permit
rapid and reliable determinations of phenobarbital and
phenytoin in serum.
The results of the enzyme immunoassays for phenytoin
and phenobarbital correlated well with those obtained
by gas-liquid chromatography. No clinically significant
difference was found, so that the Emit results would not
change the clinical interpretation.
Compared with gas-liquid chromatography the Emit
technique has the following advantages: the tests require
a sample volume of only 10 serum per determination
and can easily be mechanized. One technician is able
to analyze 30 unknown samples (duplicate determina^
tions) by an Eppendorf analyzer 5010 within 90 minutes.
This time however can be reduced to about 60 minutes,
if the Eppendorf analyzer is connected on-line to an
electronic data processing system (Forth, A. & Oellerich,
M., in preparation).
Unfortunately the costs for the Emit reagents are rather
high. If 30 samples were analyzed the price including
reagents, pertinent supplies, standards and technician
time was about 5 US$ per Emit test. Single determina-
tions are much more expensive (tab. 6).
Tab. 6. Costs of a quantitative determination of phenobarbital
or phenytoin by Emit adapted to the Eppendorf ana-
lyzer 5010.


















Total US $ 45.61 8.02 5.79 5.03
a) n = number of specimens per series; b) costs per minute
technician time: 0.11 US $.
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